Impact of plasma Epstein-Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection.

Cheng LinMeifang LiYingying LinYu ZhangHanchuan XuBijuan ChenXia YanYun Xu

Published in: Infectious agents and cancer (2024)

For NPC patients infected with SARS-CoV-2, EBV DNA alone is insufficient for monitoring relapse after radical therapy. Long-term follow-up and underlying mechanistic investigations of EBV DNA changes are urgently needed.

Keyphrases

epstein barr virus
end stage renal disease
diffuse large b cell lymphoma
ejection fraction
newly diagnosed
chronic kidney disease
circulating tumor
prognostic factors
single molecule
peritoneal dialysis
cell free
stem cells
coronavirus disease
smoking cessation